{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:35:11Z","timestamp":1785267311639,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018044","name":"Verily Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018044","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We examined multi-dimensional clinical and laboratory data in participants with normoglycemia, prediabetes, and diabetes to identify characteristics of prediabetes and predictors of progression from prediabetes to diabetes or reversion to no diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Project Baseline Health Study (PBHS) is a multi-site prospective cohort study of 2502 adults that conducted deep clinical phenotyping through imaging, laboratory tests, clinical assessments, medical history, personal devices, and surveys. Participants were classified by diabetes status (diabetes [DM], prediabetes [preDM], or no diabetes [noDM]) at each visit based on glucose, HbA1c, medications, and self-report. Principal component analysis (PCA) was performed to create factors that were compared across groups cross-sectionally using linear models. Logistic regression was used to identify factors associated with progression from preDM to DM and for reversion from preDM to noDM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At enrollment, 1605 participants had noDM; 544 had preDM; and 352 had DM. Over 4 years of follow-up, 52 participants with preDM developed DM and 153 participants reverted to noDM. PCA identified 33 factors composed of clusters of clinical variables; these were tested along with eight individual variables identified <jats:italic>a priori<\/jats:italic> as being of interest. Six PCA factors and six <jats:italic>a priori<\/jats:italic> variables significantly differed between noDM and both preDM and DM after false discovery rate adjustment for multiple comparisons (q\u2009&lt;\u20090.05). Of these, two factors (one comprising glucose measures and one of anthropometry and physical function) demonstrated monotonic\/graded relationships across the groups, as did three <jats:italic>a priori<\/jats:italic> variables: ASCVD risk, coronary artery calcium, and triglycerides (q\u2009&lt;\u200910<jats:sup>\u201321<\/jats:sup> for all). Four factors were significantly different between preDM and noDM, but concordant or similar between DM and preDM: red blood cell indices (q\u2009=\u20098\u2009\u00d7\u200910<jats:sup>-10<\/jats:sup>), lung function (q\u2009=\u20092\u2009\u00d7\u200910<jats:sup>-6<\/jats:sup>), risks of chronic diseases (q\u2009=\u20097\u2009\u00d7\u200910<jats:sup>-4<\/jats:sup>), and cardiac function (q\u2009=\u20090.001), along with <jats:italic>a priori<\/jats:italic> variables of diastolic function (q\u2009=\u20091\u2009\u00d7\u200910<jats:sup>-10<\/jats:sup>), sleep efficiency (q\u2009=\u20099\u2009\u00d7\u200910<jats:sup>-6<\/jats:sup>) and sleep time (q\u2009=\u20096\u2009\u00d7\u200910<jats:sup>-5<\/jats:sup>). Two factors were associated with progression from prediabetes to DM: anthropometry and physical function (OR [95% CI]: 0.6 [0.5, 0.9], q\u2009=\u20090.04), and heart failure and c-reactive protein (OR [95% CI]: 1.4 [1.1, 1.7], q\u2009=\u20090.02). The anthropometry and physical function factor was also associated with reversion from prediabetes to noDM: (OR [95% CI]: 1.9 [1.4, 2.7], q\u2009=\u20090.02) along with a factor of white blood cell indices (OR [95% CI]: 0.6 [0.4, 0.8], q\u2009=\u20090.02), and the <jats:italic>a priori<\/jats:italic> variables ASCVD risk score (OR [95% CI]: 0.7 [0.6, 0.9] for each 0.1 increase in ASCVD score, q\u2009=\u20090.02) and triglycerides (OR [95% CI]: 0.9 [0.8, 1.0] for each 25\u00a0mg\/dl increase, q\u2009=\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PBHS participants with preDM demonstrated pathophysiologic changes in cardiac, pulmonary, and hematology measures and declines in physical function and sleep measures that precede DM; some changes predicted an increased risk of progression to DM. A factor with measures of anthropometry and physical function was the most important factor associated with progression to DM and reversion to noDM. Future studies may determine whether these changes elucidate pathways of progression to DM and related complications and whether they can be used to identify individuals at higher risk of progression to DM for targeted preventive interventions.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> ClinicalTrials.gov NCT03154346<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01565-x","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T18:08:37Z","timestamp":1658167717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multi-dimensional characterization of prediabetes in the Project Baseline Health Study"],"prefix":"10.1186","volume":"21","clinical-trial-number":[{"clinical-trial-number":"nct03154346","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ranee","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Coulter","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne H.","family":"Koweek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyatham S.","family":"Mettu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Mega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svati H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Project Baseline Health Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.","journal-title":"BMJ"},{"issue":"9","key":"1565_CR2","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2337\/dc18-1226","volume":"42","author":"TM Dall","year":"2019","unstructured":"Dall TM, Yang W, Gillespie K, Mocarski M, Byrne E, Cintina I, et al. The economic burden of elevated blood glucose levels in 2017: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2019;42(9):1661\u20138.","journal-title":"Diabetes Care"},{"key":"1565_CR3","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html. Accessed 5\u00a0 Feb\u00a02022."},{"key":"1565_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41746-020-0290-y","volume":"3","author":"K Arges","year":"2020","unstructured":"Arges K, Assimes T, Bajaj V, Balu S, Bashir MR, Beskow L, et al. The Project Baseline Health Study: a step towards a broader mission to map human health. NPJ Digit Med. 2020;3:84.","journal-title":"NPJ Digit Med"},{"issue":"7","key":"1565_CR5","doi-asserted-by":"publisher","first-page":"e0254153","DOI":"10.1371\/journal.pone.0254153","volume":"16","author":"S Sayeed","year":"2021","unstructured":"Sayeed S, Califf R, Green R, Wong C, Mahaffey K, Gambhir SS, et al. Return of individual research results: What do participants prefer and expect? PLoS One. 2021;16(7):e0254153.","journal-title":"PLoS One"},{"issue":"2","key":"1565_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2213-8587(13)70046-9","volume":"1","author":"E Wong","year":"2013","unstructured":"Wong E, Backholer K, Gearon E, Harding J, Freak-Poli R, Stevenson C, et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1(2):106\u201314.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1565_CR7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2337\/diacare.28.10.2541","volume":"28","author":"AA Sayer","year":"2005","unstructured":"Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DI, Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care. 2005;28(10):2541\u20132.","journal-title":"Diabetes Care"},{"issue":"10","key":"1565_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00592-018-1192-1","volume":"55","author":"MJ Astrom","year":"2018","unstructured":"Astrom MJ, von Bonsdorff MB, Perala MM, Salonen MK, Rantanen T, Kajantie E, et al. Glucose regulation and physical performance among older people: the Helsinki Birth Cohort Study. Acta Diabetol. 2018;55(10):1051\u20138.","journal-title":"Acta Diabetol"},{"issue":"6","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00592-016-0880-y","volume":"53","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient\u2019s mobility and independence. Acta Diabetol. 2016;53(6):879\u201389.","journal-title":"Acta Diabetol"},{"issue":"6","key":"1565_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11892-013-0424-6","volume":"13","author":"L Bianchi","year":"2013","unstructured":"Bianchi L, Zuliani G, Volpato S. Physical disability in the elderly with diabetes: epidemiology and mechanisms. Curr Diabetes Rep. 2013;13(6):824\u201330.","journal-title":"Curr Diabetes Rep"},{"issue":"5","key":"1565_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1249\/MSS.0000000000002238","volume":"52","author":"JW Senefeld","year":"2020","unstructured":"Senefeld JW, Harmer AR, Hunter SK. Greater Lower Limb Fatigability in People with Prediabetes than Controls. Med Sci Sports Exerc. 2020;52(5):1176\u201386.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"1565_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med"},{"key":"1565_CR13","unstructured":"Centers for Disease Control and Prevention. Prevent Type 2 Diabetes. https:\/\/www.cdc.gov\/diabetes\/prevent-type-2\/index.html. Accessed 5 Feb\u00a02022."},{"issue":"Supplement_1","key":"1565_CR14","first-page":"S39-S45","volume":"45","author":"C Practice","year":"2022","unstructured":"American Diabetes Association Professional, Practice C, American Diabetes Association Professional, Practice C, Draznin B, Aroda VR, Bakris G, Benson G, et al. 3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S39\u201345.","journal-title":"Diabetes Care"},{"issue":"6","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00249-021-01541-5","volume":"50","author":"Y Singh","year":"2021","unstructured":"Singh Y, Chowdhury A, Dasgupta R, Majumder SK. The effects of short term hyperglycemia on human red blood cells studied using Raman spectroscopy and optical trap. Eur Biophys J. 2021;50(6):867\u201376.","journal-title":"Eur Biophys J"},{"key":"1565_CR16","first-page":"6656062","volume":"2021","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang P, Yan Z, Liu Z, Ma Q, Zhang Z, et al. The Relationship between Erythrocytes and Diabetes Mellitus. J Diabetes Res. 2021;2021:6656062.","journal-title":"J Diabetes Res"},{"issue":"3","key":"1565_CR17","first-page":"209","volume":"17","author":"V Turchetti","year":"1997","unstructured":"Turchetti V, De Matteis C, Leoncini F, Trabalzini L, Guerrini M, Forconi S. Variations of erythrocyte morphology in different pathologies. Clin Hemorheol Microcirc. 1997;17(3):209\u201315.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"9","key":"1565_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","volume":"27","author":"OL Klein","year":"2021","unstructured":"Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med. 2021;27(9):977\u201387.","journal-title":"Diabet Med."},{"issue":"6","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2337\/diacare.28.6.1472","volume":"28","author":"HC Yeh","year":"2005","unstructured":"Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(6):1472\u20139.","journal-title":"Diabetes Care"},{"issue":"2","key":"1565_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11606-013-2569-z","volume":"29","author":"R Chatterjee","year":"2014","unstructured":"Chatterjee R, Brancati FL, Shafi T, Edelman D, Pankow JS, Mosley TH, et al. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014;29(2):290\u20137.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"1565_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1479164118787415","volume":"15","author":"S Bouthoorn","year":"2018","unstructured":"Bouthoorn S, Valstar GB, Gohar A, den Ruijter HM, Reitsma HB, Hoes AW, et al. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Diab Vasc Dis Res. 2018;15(6):477\u201393.","journal-title":"Diab Vasc Dis Res"},{"issue":"12","key":"1565_CR22","doi-asserted-by":"publisher","first-page":"e0209794","DOI":"10.1371\/journal.pone.0209794","volume":"13","author":"G Zoppini","year":"2018","unstructured":"Zoppini G, Bergamini C, Mantovani A, Dauriz M, Targher G, Rossi A, et al. The E\/e\u2019 ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies. PLoS One. 2018;13(12):e0209794.","journal-title":"PLoS One"},{"issue":"3","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.114.001990","volume":"8","author":"H Skali","year":"2015","unstructured":"Skali H, Shah A, Gupta DK, Cheng S, Claggett B, Liu J, et al. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail. 2015;8(3):448\u201354.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"1565_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/dc12-0702","volume":"36","author":"X Wang","year":"2013","unstructured":"Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36(1):166\u201375.","journal-title":"Diabetes Care"},{"issue":"10","key":"1565_CR25","doi-asserted-by":"publisher","first-page":"e13405","DOI":"10.1371\/journal.pone.0013405","volume":"5","author":"E Gkrania-Klotsas","year":"2010","unstructured":"Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One. 2010;5(10):e13405.","journal-title":"PLoS One"},{"issue":"4","key":"1565_CR26","doi-asserted-by":"publisher","first-page":"e3125","DOI":"10.1002\/dmrr.3125","volume":"35","author":"X Zang","year":"2019","unstructured":"Zang X, Meng X, Wang Y, Jin X, Wu T, Liu X, et al. Six-year follow-up study on the association between white blood cell count and fasting blood glucose level in Chinese adults: A community-based health examination survey. Diabetes Metab Res Rev. 2019;35(4):e3125.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"1565_CR27","first-page":"445","volume":"22","author":"AA Boucher","year":"2012","unstructured":"Boucher AA, Edeoga C, Ebenibo S, Wan J, Dagogo-Jack S. Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes: the Pathobiology of Prediabetes in a Biracial Cohort study. Ethn Dis. 2012;22(4):445\u201350.","journal-title":"Ethn Dis"},{"issue":"13","key":"1565_CR28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","volume":"55","author":"ES Ford","year":"2010","unstructured":"Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55(13):1310\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1565_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smrv.2015.10.002","volume":"30","author":"T Anothaisintawee","year":"2016","unstructured":"Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev. 2016;30:11\u201324.","journal-title":"Sleep Med Rev"},{"issue":"2","key":"1565_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2015.09.038","volume":"243","author":"RM Zagami","year":"2015","unstructured":"Zagami RM, Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c. Atherosclerosis. 2015;243(2):395\u2013401.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1565_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2337\/dc16-1541","volume":"40","author":"SP Whelton","year":"2017","unstructured":"Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2017;40(2):261\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"1565_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10654-017-0236-0","volume":"32","author":"A Brahimaj","year":"2017","unstructured":"Brahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217\u201326.","journal-title":"Eur J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01565-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T18:09:02Z","timestamp":1658167742000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01565-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) at each clinical site approved the protocol, and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors acknowledge institutional research grants from Verily Life Sciences. FH received an institutional research grant from Actelion Ltd. within the last 2 years and an institutional research grant from Precordior Ltd. KM reports grants from Verily, Afferent, the American Heart Association (AHA), Cardiva Medical Inc, Gilead, Luitpold, Medtronic, Merck, Eidos, Ferring, Apple Inc, Sanifit, and St. Jude; grants and personal fees from Amgen, AstraZeneca, Bayer, CSL Behring, Johnson & Johnson, Novartis, and Sanofi; and personal fees from Anthos, Applied Therapeutics, Elsevier, Inova, Intermountain Health, Medscape, Mount Sinai, Mundi Pharma, Myokardia, Novo Nordisk, Otsuka, Portola, SmartMedics, and Theravance outside the submitted work. AH reports grants from Verily; grants and personal fees from AstraZeneca, Amgen, Bayer, Merck, and Novartis; and personal fees from Boston Scientific outside the submitted work. FR reports equity from HealthPals and Carta, and advisory board and consulting fees from NovoNordisk, HealthPals, and Novartis. The other authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}